Main menu


Moderna is applying for full FDA approval for the Corona vaccine

Moderna, today, Tuesday, applied to obtain the full approval of the US Food and Drug Administration (FDA) for the Corona vaccine, becoming the second pharmaceutical company to do so after Pfizer and its German partner BioNTech, which sought to obtain a full permit for the vaccine last month, according to what she said. Reuters.

The approval of the US Food and Drug Administration (FDA) for the emergency use of health regulatory agencies allowed the approval of vaccines during the epidemic, based on a minimum number of corona infection among the experimental population and two months of safety data for vaccine recipients.

Moderna said it will continue to provide the data to the FDA in the coming weeks, with a request for a priority review, adding that upon completion of the submission, the agency will notify the company when it is formally accepted for review.

Cambridge-based Moderna has an agreement with the United States government to supply 300 million doses of the Corona vaccine, authorized or approved for use in more than 40 countries.

More than 151 million doses of the Moderna vaccine have been distributed across the United States, with nearly 124.5 million doses as of May 30, according to the US Centers for Disease Control and Prevention.

The agency said that more than 135 million people, or roughly 41% of the total US population, had been fully vaccinated as of May 30, according to CDC data.

Moderna said in April that its vaccine showed strong protection against the Corona virus, 6 months after people received the second dose, with more than 95% effectiveness against the emerging corona virus.